Avricore Health Inc. (TSXV:AVCR)

Avricore Health Statistics

Total Valuation

Avricore Health has a market cap or net worth of CAD 5.57 million. The enterprise value is 5.33 million.

Market Cap	5.57M
Enterprise Value	5.33M

Important Dates

The next estimated earnings date is Monday, June 1, 2026.

Earnings Date	Jun 1, 2026
Ex-Dividend Date	n/a

Share Statistics

Avricore Health has 101.29 million shares outstanding. The number of shares has increased by 0.97% in one year.

Current Share Class	101.29M
Shares Outstanding	101.29M
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.60%
Owned by Institutions (%)	n/a
Float	92.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.43
PB Ratio	14.30
P/TBV Ratio	14.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.87
EV / Sales	9.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.07

Financial Position

The company has a current ratio of 2.11

Current Ratio	2.11
Quick Ratio	1.59
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -157.70% and return on invested capital (ROIC) is -65.04%.

Return on Equity (ROE)	-157.70%
Return on Assets (ROA)	-53.58%
Return on Invested Capital (ROIC)	-65.04%
Return on Capital Employed (ROCE)	-314.87%
Weighted Average Cost of Capital (WACC)	6.16%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.37
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.33% in the last 52 weeks. The beta is 0.35, so Avricore Health's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-8.33%
50-Day Moving Average	0.07
200-Day Moving Average	0.06
Relative Strength Index (RSI)	40.23
Average Volume (20 Days)	43,862

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Avricore Health had revenue of CAD 533,884 and -1.86 million in losses. Loss per share was -0.02.

Revenue	533,884
Gross Profit	238,295
Operating Income	-1.23M
Pretax Income	-1.86M
Net Income	-1.86M
EBITDA	-1.09M
EBIT	-1.23M
Loss Per Share	-0.02

Balance Sheet

The company has 237,918 in cash and n/a in debt, with a net cash position of 237,918 or 0.00 per share.

Cash & Cash Equivalents	237,918
Total Debt	n/a
Net Cash	237,918
Net Cash Per Share	0.00
Equity (Book Value)	389,564
Book Value Per Share	0.00
Working Capital	192,772

Cash Flow

In the last 12 months, operating cash flow was -789,933 and capital expenditures -88,497, giving a free cash flow of -878,430.

Operating Cash Flow	-789,933
Capital Expenditures	-88,497
Depreciation & Amortization	139,615
Net Borrowing	n/a
Free Cash Flow	-878,430
FCF Per Share	-0.01

Margins

Gross Margin	44.63%
Operating Margin	-229.75%
Pretax Margin	-348.16%
Profit Margin	n/a
EBITDA Margin	-203.60%
EBIT Margin	-229.75%
FCF Margin	n/a

Dividends & Yields

Avricore Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.97%
Shareholder Yield	-0.97%
Earnings Yield	-33.37%
FCF Yield	-15.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.25.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	0.25

Scores

Altman Z-Score	n/a
Piotroski F-Score	2